SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Idiopathic Pulmonary Fibrosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Zuojun Xu, Medical Doctor) · Xuzj@hotmail.com · +86 010-69156114

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF

Idiopathic Pulmonary Fibrosis (IPF)

Abroad (travel likely)RecruitingPHASE3

Beijing, China

A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Abroad (travel likely)RecruitingPHASE2

Skopje, North Macedonia

Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis · Idiopathic Pulmonary Fibrosis (IPF)

Abroad (travel likely)RecruitingPHASE2

Danbury, United States · Windsor, Canada

A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

Idiopathic Pulmonary Fibrosis

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Gainesville, United States